Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies

References

• World Health Organization. Global health estimates 2019: the top 10 causes of death, 2000–2019; 2020. Available from: https://www.who.int/data/global-health-estimates. Accessed November 24, 2021.
   Google Scholar
• Global Burden of Disease Project Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. doi:10.1016/S0140-6736(17)32152-9
   PubMed Web of Science ®Google Scholar
• Wedzichia JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013;11:18. doi:10.1186/1741-7015-11-181
   Google Scholar
• Mathioudakis AG, Janssens W, Sivapalan P, et al. Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits. Thorax. 2020;75(6):520–527. doi:10.1136/thoraxjnl-2019-214484
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet (London, England). 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management; 2018. Available from: https://www.nice.org.uk/guidance/ng115/chapter/Recommendations. Accessed November 24, 2021.
   Google Scholar
• Rothnie KJ, Müllerová H, Smeeth L, Quint JK. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(4):464–471.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Patel IS, Lloyd-Owen SJ, Wilkinson TM, Wedzicha JA. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J. 2003;22(6):931–936. doi:10.1183/09031936.03.00038303
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(3):324–330. doi:10.1164/rccm.201605-1014OC
   PubMed Web of Science ®Google Scholar
• Whittaker HR, Pimenta JM, Jarvis D, Kiddle SJ, Quint JK. Characteristics associated with accelerated lung function decline in a primary care population with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:3079–3091. doi:10.2147/COPD.S278981
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422. doi:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Halpin DM, Miravitlles M, Metzdorf N, Celli B. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi:10.2147/COPD.S139470
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Sullivan SD. The burden of illness and economic evaluation for COPD. Eur Respir J Suppl. 2003;21:29s–35s. doi:10.1183/09031936.03.00078203
   Google Scholar
• Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest. 2001;119(2):344–352. doi:10.1378/chest.119.2.344
   PubMed Web of Science ®Google Scholar
• Wedzicha C, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49(3):1600791. doi:10.1183/13993003.00791-2016
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-196
   PubMed Web of Science ®Google Scholar
• Montes de Oca M, Laucho-Contreras ME. Is it time to change the definition of acute exacerbation of chronic obstructive pulmonary disease? What do we need to add? Med Sci. 2018;6(2):50. doi:10.3390/medsci6020050
   Google Scholar
• Leidy NK, Sexton CC, Jones PW, et al. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax. 2014;69(5):443–449. doi:10.1136/thoraxjnl-2013-204428
   PubMed Web of Science ®Google Scholar
• O’Reilly JF, Williams AE, Holt K, Rice L. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J. 2006;15(6):346–353. doi:10.1016/j.pcrj.2006.08.009
   PubMedGoogle Scholar
• Murray LT, Leidy NK. The short-term impact of symptom-defined COPD exacerbation recovery on health status and lung function. Chron Obstruct Pulmon Dis. 2018;5(1):27–37. doi:10.15326/jcopdf.5.1.2017.0166
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Müllerová H, Hurst JR, et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. PLoS One. 2016;11(3):e0151357. doi:10.1371/journal.pone.0151357
   PubMed Web of Science ®Google Scholar
• Pauwels R, Calverley P, Buist AS, et al. COPD exacerbations: the importance of a standard definition. Respir Med. 2004;98(2):99–107. doi:10.1016/j.rmed.2003.09.001
   PubMed Web of Science ®Google Scholar
• Caramori G, Adcock IM, Papi A. Clinical definition of COPD exacerbations and classification of their severity. South Med J. 2009;102(3):277–282. doi:10.1097/SMJ.0b013e3181836b73
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
   Web of Science ®Google Scholar
• Cydulka RK, Rowe BH, Clark S, Emerman CL, Camargo CA Jr. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: the Multicenter Airway Research Collaboration. J Am Geriatr Soc. 2003;51(7):908–916. doi:10.1046/j.1365-2389.2003.51302.x
   PubMed Web of Science ®Google Scholar
• Hurst JR, Donaldson GC, Quint JK, Goldring JJ, Baghai-Ravary R, Wedzicha JA. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(5):369–374. doi:10.1164/rccm.200807-1067OC
   PubMed Web of Science ®Google Scholar
• Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respir Int Rev Thorac Dis. 2012;84(1):17–26. doi:10.1159/000335467
   Web of Science ®Google Scholar
• Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest. 2002;121(3):688–696. doi:10.1378/chest.121.3.688
   PubMed Web of Science ®Google Scholar
• Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000;117(5):1345–1352. doi:10.1378/chest.117.5.1345
   PubMed Web of Science ®Google Scholar
• Domenech A, Ardanuy C, Pallares R, et al. Some pneumococcal serotypes are more frequently associated with relapses of acute exacerbations in COPD patients. PLoS One. 2013;8(3):e59027. doi:10.1371/journal.pone.0059027
   PubMed Web of Science ®Google Scholar
• Durmaz D, Goksu E, Kilic T, Ozbudak O, Eray O. The role of nitric oxide in predicting revisit of patients with exacerbated chronic obstructive pulmonary disease. J Emerg Med. 2015;48(2):247–253. doi:10.1016/j.jemermed.2014.06.026
   PubMed Web of Science ®Google Scholar
• Durmaz D, Goksu E, Yildiz G, et al. The factors influencing relapse in patients presenting to the emergency department with COPD exacerbation. Turk J Emerg Med. 2015;15(2):59–63. doi:10.5505/1304.7361.2014.37791
   PubMedGoogle Scholar
• Kim S, Emerman CL, Cydulka RK, Rowe BH, Clark S, Camargo CA. Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. Chest. 2004;125(2):473–481. doi:10.1378/chest.125.2.473
   PubMed Web of Science ®Google Scholar
• Minov J, Stoleski S, Petrova T, Vasilevska K, Mijakoski D, Bislimovska-Karadzhinska J. Moxifloxacin in the outpatient treatment of moderate exacerbations of chronic obstructive pulmonary disease. Open Access Macedon J Med Sci. 2018;6(11):2017–2022. doi:10.3889/oamjms.2018.445
   PubMedGoogle Scholar
• Miravitlles M, Murio C, Guerrero T. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group. Eur Respir J. 2001;17(5):928–933. doi:10.1183/09031936.01.17509280
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Zalacain R, Murio C, et al. Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials: results of a two-year study. Clin Drug Investig. 2003;23(7):439–450. doi:10.2165/00044011-200323070-00003
   PubMed Web of Science ®Google Scholar
• Stiell IG, Perry JJ, Clement CM, et al. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department. CMAJ. 2018;190(48):E1406–E1413. doi:10.1503/cmaj.180232
   PubMed Web of Science ®Google Scholar
• Vondracek SF, Hemstreet BA. Retrospective evaluation of systemic corticosteroids for the management of acute exacerbations of chronic obstructive pulmonary disease. Am J Health Sys Pharm. 2006;63(7):645–652. doi:10.2146/ajhp050316
   PubMed Web of Science ®Google Scholar
• Bartziokas K, Papaioannou AI, Loukides S, et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J. 2014;43(1):43–53. doi:10.1183/09031936.00209212
   PubMed Web of Science ®Google Scholar
• Bathoorn E, Groenhof F, Hendrix R, et al. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care. Int J Chron Obstruct Pulmon Dis. 2017;12:285–290. doi:10.2147/COPD.S120510
   PubMed Web of Science ®Google Scholar
• Chang C, Yao W. Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease. Med Sci Monit. 2014;20:311–320. doi:10.12659/MSM.889828
   PubMed Web of Science ®Google Scholar
• Cushen B, McCormack N, Hennigan K, Sulaiman I, Costello RW, Deering B. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program. Respir Med. 2016;119:55–62. doi:10.1016/j.rmed.2016.08.019
   PubMed Web of Science ®Google Scholar
• Hu WP, Lhamo T, Liu D, et al. Development of a nomogram to predict the risk of 30-day re-exacerbation for patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. COPD. 2019;16(2):160–167. doi:10.1080/15412555.2019.1606187
   PubMedGoogle Scholar
• Johannesdottir SA, Christiansen CF, Johansen MB, et al. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ. 2013;16(7):897–906. doi:10.3111/13696998.2013.800525
   PubMedGoogle Scholar
• Liu D, Peng SH, Zhang J, Bai SH, Liu HX, Qu JM. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1265–1273. doi:10.2147/COPD.S83378
   PubMed Web of Science ®Google Scholar
• Perera WR, Hurst JR, Wilkinson TM, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29(3):527–534. doi:10.1183/09031936.00092506
   PubMed Web of Science ®Google Scholar
• Wang L, Zang XY, Zhang Q, Liu SY, Shen YH, Zhao Y. Study on factors influencing recrudescent time of postdischarge patients with chronic obstructive pulmonary disease. J Clin Nurs. 2012;21(11–12):1507–1514. doi:10.1111/j.1365-2702.2011.03899.x
   PubMed Web of Science ®Google Scholar
• Yount SE, Atwood C, Donohue J, et al. Responsiveness of PROMIS(R) to change in chronic obstructive pulmonary disease. J Patient Rep Outcomes. 2019;3(1):65. doi:10.1186/s41687-019-0155-9
   PubMedGoogle Scholar
• Beauchesne MF, Julien M, Julien LA, et al. Antibiotics used in the ambulatory management of acute COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2008;3(2):319–322. doi:10.2147/COPD.S2624
   PubMedGoogle Scholar
• Crisafulli E, Torres A, Huerta A, et al. Predicting in-hospital treatment failure (</= 7 days) in patients with COPD exacerbation using antibiotics and systemic steroids. COPD. 2016;13(1):82–92. doi:10.3109/15412555.2015.1057276
   PubMedGoogle Scholar
• Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest. 2000;117(3):662–671. doi:10.1378/chest.117.3.662
   PubMed Web of Science ®Google Scholar
• Garcia-Sidro P, Naval E, Martinez Rivera C, et al. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations. Respir Med. 2015;109(12):1546–1552. doi:10.1016/j.rmed.2015.10.011
   PubMed Web of Science ®Google Scholar
• Gaude GS, Rajesh BP, Chaudhury A, Hattiholi J. Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization. Lung India. 2015;32(5):465–472. doi:10.4103/0970-2113.164150
   PubMedGoogle Scholar
• Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359–2367. doi:10.1001/jama.2010.796
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Llor C, Naberan K, Cots JM, Molina J; EFEMAP study group. Group Es. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Respir Med. 2005;99(8):955–965. doi:10.1016/j.rmed.2005.01.013
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Izquierdo I, Herrejon A, et al. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respir Med. 2011;105(5):740–747. doi:10.1016/j.rmed.2010.12.020
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Garcia-Polo C, Domenech A, Villegas G, Conget F, de la Roza C. Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease. Lung. 2013;191(5):523–530. doi:10.1007/s00408-013-9487-z
   PubMed Web of Science ®Google Scholar
• Planquette B, Peron J, Dubuisson E, et al. Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study. Int J Chron Obstruct Pulmon Dis. 2015;10:379–388. doi:10.2147/COPD.S71413
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). J Hosp Med. 2010;5(5):261–267. doi:10.1002/jhm.628
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA. 2010;303(20):2035–2042. doi:10.1001/jama.2010.672
   PubMed Web of Science ®Google Scholar
• Anzueto A, Miravitlles M, Ewig S, Legnani D, Heldner S, Stauch K. Identifying patients at risk of late recovery (>/= 8 days) from acute exacerbation of chronic bronchitis and COPD. Respir Med. 2012;106(9):1258–1267. doi:10.1016/j.rmed.2012.06.002
   PubMed Web of Science ®Google Scholar
• Aaron SD, Whitmore GA, Hurst JR, Ramsay T, Wedzicha JA. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67(3):238–243. doi:10.1136/thoraxjnl-2011-200768
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–1303. doi:10.1164/rccm.200310-1443OC
   PubMed Web of Science ®Google Scholar
• Liang Y, Chen Y, Wu R, et al. Chronic bronchitis is associated with severe exacerbation and prolonged recovery period in Chinese patients with COPD: a multicenter cross-sectional study. J Thorac Dis. 2017;9(12):5120–5130. doi:10.21037/jtd.2017.11.54
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Donaldson GC, Patel AR, Singh R, Kowlessar B, Wedzicha JA. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT). Eur Respir J. 2014;43(3):735–744. doi:10.1183/09031936.00110913
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Anzueto A, Ewig S, Legnani D, Stauch K. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. Ther Adv Respir Dis. 2009;3(6):267–277. doi:10.1177/1753465809352791
   PubMedGoogle Scholar
• Farias R, Sedeno M, Beaucage D, et al. Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence. BMJ Open Respir Res. 2019;6(1):e000379. doi:10.1136/bmjresp-2018-000379
   PubMed Web of Science ®Google Scholar
• Tsai CL, Rowe BH, Camargo CA Jr. Factors associated with short-term recovery of health status among emergency department patients with acute exacerbations of chronic obstructive pulmonary disease. Qual Life Res. 2009;18(2):191–199. doi:10.1007/s11136-008-9437-z
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi:10.1164/ajrccm.161.5.9908022
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Law M, Kowlessar B, et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(8):943–950. doi:10.1164/rccm.201412-2269OC
   PubMed Web of Science ®Google Scholar
• Aaron SD, Donaldson GC, Whitmore GA, Hurst JR, Ramsay T, Wedzicha JA. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67(3):238–243. doi:10.1136/thoraxjnl-2011-200768
   PubMed Web of Science ®Google Scholar
• McIlvennan CK, Eapen ZJ, Allen LA. Hospital readmissions reduction program. Circulation. 2015;131(20):1796–1803. doi:10.1161/CIRCULATIONAHA.114.010270
   PubMed Web of Science ®Google Scholar
• Trappenburg JC, Schaap D, Monninkhof EM, et al. How do COPD patients respond to exacerbations? BMC Pulm Med. 2011;11:43. doi:10.1186/1471-2466-11-43
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PM, Decramer M, Stockley RA, Wedzicha JA. Prevention of exacerbations in chronic obstructive pulmonary disease: knowns and unknowns. COPD. 2014;1(2):166–184. doi:10.15326/jcopdf.1.2.2014.0134
   PubMedGoogle Scholar
• Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest. 2002;121(5, Supplement):136S–141S. doi:10.1378/chest.121.5_suppl.136S
   PubMed Web of Science ®Google Scholar
• Meeraus W, Mullerova H, Tabberer M, Fahy WA, Benson VS. Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs). Eur Respirat J. 2018;52(suppl 62):PA1171.
   Google Scholar